OR WAIT null SECS
Medidata's ClinicalCloud will provide scalable technology to Celltrion's biosimilars development programs.
Seoul, Korea-based biopharmaceutical company Celltrion announced it has adopted Medidata's ClinicalCloud to provide scalable technology to its biosimilars development programs. The technologies include electronic data capture and management (Medidata Rave®), medical coding (Medidata Coder®) and randomization and trial supply management (Medidata Balance®).
Read the full release.